Clinical Trial Update: Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 3]

View source ↗

Summary

Phase 3 trial update on neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable hepatocellular carcinoma beyond Milan criteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN